FORSYTH DOUGLAS 4
4 · Inhibrx Biosciences, Inc. · Filed Aug 26, 2024
Insider Transaction Report
Form 4
FORSYTH DOUGLAS
Director
Transactions
- Purchase
Common Stock
2024-08-23$14.07/sh+59,812$841,555→ 224,564 total(indirect: By Trust) - Purchase
Common Stock
2024-08-22$12.89/sh+15,188$195,773→ 164,752 total(indirect: By Trust)
Footnotes (3)
- [F1]The shares were purchased in multiple transactions at prices ranging from $12.80 to $13.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The reporting person is a trustee of the Forsyth Family Trust Dated July 20, 2001 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Forsyth Family Trust Dated July 20, 2001.
- [F3]The shares were purchased in multiple transactions at prices ranging from $13.48 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.